Evidence map›Paper›PMID 35984558›Full record

ArticleInternational ophthalmology2022

ALT (allogeneic limbal transplantation): a new surgical technique for limbal stem cell deficiency.

Anja Viestenz, Christiane Kesper, Thomas Hammer, Joana Heinzelmann, Sabine Foja, Arne Viestenz

Open access · hybridAbstract read
In one paragraph

Article in International ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anja ViestenzDepartment of Ophthalmology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Ernst-Grube Straße 40, 06120, Halle, Germany. anja.viestenz@uk-halle.de.ORCID http://orcid.org/0000-0002-7919-4025
Christiane KesperDepartment of Ophthalmology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Ernst-Grube Straße 40, 06120, Halle, Germany.
Thomas HammerDepartment of Ophthalmology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Ernst-Grube Straße 40, 06120, Halle, Germany.
Joana HeinzelmannDepartment of Ophthalmology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Ernst-Grube Straße 40, 06120, Halle, Germany.
Sabine FojaDepartment of Ophthalmology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Ernst-Grube Straße 40, 06120, Halle, Germany.
Arne ViestenzDepartment of Ophthalmology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Ernst-Grube Straße 40, 06120, Halle, Germany.
Martin Luther University Halle-Wittenberg · DEUniversity Hospital in Halle · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLimbal stem cell deficiency (LSCD) is a rare but extremely relevant disease of the eye. LSCD patients often require a variety of surgical procedures, including keratoplasty in some cases. However, the outcome of these surgeries, including opacification and revascularization, is often frustrating due to LSCD relapse.

methodsWe developed a new surgical technique for the treatment of LSCD in which partial allogenic limbal transplantation (ALT) is carried out as part of penetrating keratoplasty (PK). After the PK, 1-8 slices from the limbal tissue of the donor graft are prepared and placed under the double running sutures attaching the corneal graft. This procedure was performed on 14 patients with LSCD, caused by severe ocular burn in 5 cases and by infection in 9. Between one and eight limbal transplants were used depending on the extension of the LSCD.

resultsAll 14 patients showed stable or increased visual acuity after the ALT surgery compared to their preoperative visual acuity. All of the grafts were integrated into the superficial corneal layers without progression of corneal vascularization beyond the limbal grafts. The median follow-up period was 12 months on average.

conclusionThe ALT method seems to be a promising surgical procedure for the treatment of patients with LSCD. It can be properly carried out in the context of keratoplasty and does not require a separate donor tissue. The ALT grafts may offer the possibility of constructing a new limbal region, resulting in stable or even increased visual acuity and the absence of corneal vascularization.

Indexed as

Corneal DiseasesEpithelium, CornealHematopoietic Stem Cell TransplantationLimbus CorneaeScleral DiseasesFollow-Up StudiesGraft SurvivalHumansTransplantation, AutologousAllogeneic limbal transplantationCorneal burnLimbal stem cell deficiencyLimbal stem cellsPenetrating keratoplasty

Identifiers

PMID35984558
PMCPMC9617846
OpenAlexW4292314658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.